Remedent, Inc. (REMI)

Remedent Income Statement

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Revenue	0.05	0.4	0.29	0.22	1.43
Revenue Growth (YoY)	-88.53%	39.10%	31.23%	-84.59%	-34.80%
Cost of Revenue	0.03	0.23	0.14	0.09	0.43
Gross Profit	0.02	0.17	0.15	0.13	1
Selling, General & Admin	0.64	0.45	0.43	0.56	1.55
Research & Development	-	-	-	-	0
Other Operating Expenses	-0.36	-0.36	-0.31	-0.42	-
Operating Expenses	0.3	0.11	0.14	0.2	1.63
Operating Income	-0.28	0.06	0.01	-0.07	-0.64
Interest Expense	-0	-	-0	-0.01	-0.01
Interest & Investment Income	0.04	0.01	0	0	-
Earnings From Equity Investments	-	-	-	-	2.54
Other Non Operating Income (Expenses)	-0	-0	-0	-0.01	-0
EBT Excluding Unusual Items	-0.24	0.07	0.01	-0.08	1.89
Legal Settlements	0.01	-	-	-	-
Other Unusual Items	-0.08	0.06	0	-	-
Pretax Income	-0.3	0.13	0.01	-0.08	1.89
Income Tax Expense	0	0	0	0	0
Earnings From Continuing Operations	-0.3	0.13	0.01	-0.08	1.89
Minority Interest in Earnings	-	-	-	-	0.01
Net Income	-0.3	0.13	0.01	-0.08	1.9
Net Income to Common	-0.3	0.13	0.01	-0.08	1.9
Net Income Growth	-	1372.52%	-	-	-
Shares Outstanding (Basic)	-	-	-	-	20
Shares Outstanding (Diluted)	-	-	-	-	20
EPS (Basic)	-	-	-	-	0.09
EPS (Diluted)	-	-	-	-	0.09
Free Cash Flow	-	-	-	-	0.51
Free Cash Flow Per Share	-	-	-	-	0.03
Gross Margin	39.89%	42.58%	50.62%	61.22%	69.66%
Operating Margin	-599.97%	14.60%	1.80%	-30.58%	-44.73%
Profit Margin	-659.55%	32.81%	3.10%	-35.86%	132.74%
Free Cash Flow Margin	-	-	-	-	35.39%
EBITDA	-0.26	0.08	0.04	-0	-0.55
EBITDA Margin	-	20.10%	12.90%	-1.13%	-38.63%
D&A For EBITDA	0.02	0.02	0.03	0.06	0.09
EBIT	-0.28	0.06	0.01	-0.07	-0.64
EBIT Margin	-	14.60%	1.80%	-30.58%	-44.73%
Effective Tax Rate	-	0.49%	3.23%	-	0.04%
Revenue as Reported	0.41	0.77	0.62	0.65	-
Advertising Expenses	-	-	-	-	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.